Basic information
- Name:
Dibenz[b,f][1,4]oxazepine,2-chloro-11-(1-piperazinyl)-
- Superlist Name:
- Amoxapine
- CAS No.:
14028-44-5
- Molecular Structure:
![Molecular Structure of 14028-44-5 (Dibenz[b,f][1,4]oxazepine,2-chloro-11-(1-piperazinyl)-)](http://www.lookchem.com/300w/2010/0625/14028-44-5.jpg)
- Formula:
- C17H16ClN3O
- Molecular Weight:
- 313.79
- Synonyms:
- 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine;
- EINECS:
- 237-867-1
- Density:
- 1.37 g/cm3
- Melting Point:
- 175-176 °C
- Boiling Point:
- 469.9 °C at 760 mmHg
- Flash Point:
- 238 °C
- Appearance:
- Crystalline solid
- Hazard Symbols:
Xn- Risk Codes:
- 22
- Safety Description:
- 36 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Consensus Reports
Specification
The Amoxapine, with the CAS registry number 14028-44-5 and EINECS registry number 237-867-1, has the systematic name of 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine. It is a kind of crystalline solid, and belongs to the following product categories: Intermediates & Fine Chemicals; Pharmaceuticals; Adrenoceptor. It is a strong norepinephrine reuptake inhibitor and weak serotonin reuptake inhibitor. It also possesses antiadrenergic, anticholinergic, antidopaminergic, antihistamine, and antiserotonergic actions. The molecular formula of this chemical is C17H16ClN3O.
The physical properties of Amoxapine are as following: (1)ACD/LogP: 2.35; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.06; (4)ACD/LogD (pH 7.4): 1.76; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 9.32; (7)ACD/KOC (pH 5.5): 2.32; (8)ACD/KOC (pH 7.4): 117.52; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 28.07 Å2; (13)Index of Refraction: 1.685; (14)Molar Refractivity: 86.74 cm3; (15)Molar Volume: 228.2 cm3; (16)Polarizability: 34.39×10-24cm3; (17)Surface Tension: 52.1 dyne/cm; (18)Density: 1.37 g/cm3; (19)Flash Point: 238 °C; (20)Enthalpy of Vaporization: 73.23 kJ/mol; (21)Boiling Point: 469.9 °C at 760 mmHg; (22)Vapour Pressure: 5.32E-09 mmHg at 25°C.
Preparation and uses of Amoxapine: o-(p-chlorophenoxy) benzene Ethyl carbamate react with N-ethyl piperazine-based to give 4-[[o-(p-chlorophenoxy)phenyl]carbamoyl]-1-piperazine carboxylate. Then heat it with phosphorus pentoxide and phosphorus oxychloride to reflux. And you can get the aim product with this cyclization reaction. What's more, Amoxapine is used in the treatment of depression, anxiety disorders, panic disorder, and bipolar disorder.
You should be cautious while dealing with this chemical. It is harmful if swallowed. Therefore, you had better take the wear suitable protective clothing.
You can still convert the following datas into molecular structure:
(1)SMILES: Clc2ccc1Oc4c(/N=C(\c1c2)N3CCNCC3)cccc4
(2)InChI: InChI=1/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
(3)InChIKey: QWGDMFLQWFTERH-UHFFFAOYAA
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD | unreported | > 20mg/kg (20mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: IRRITABILITY | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 1, 1979. |
| child | LDLo | oral | 25mg/kg (25mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Southern Medical Journal. Vol. 76, Pg. 543, 1983. |
| child | TDLo | oral | 10mg/kg (10mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP | JAMA, Journal of the American Medical Association. Vol. 250, Pg. 1069, 1983. |
| dog | LD | unreported | > 20mg/kg (20mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: IRRITABILITY | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 1, 1979. |
| dog | LDLo | intraperitoneal | 20mg/kg (20mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 1, 1979. |
| man | TDLo | oral | 4285ug/kg/2D- (4.285mg/kg) | BEHAVIORAL: EXCITEMENT | American Journal of Psychiatry. Vol. 140, Pg. 115, 1983. |
| man | TDLo | oral | 4286ug/kg (4.286mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: REGIDITY | Southern Medical Journal. Vol. 77, Pg. 94, 1984. |
| man | TDLo | oral | 14mg/kg (14mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | JAMA, Journal of the American Medical Association. Vol. 248, Pg. 3141, 1982. |
| man | TDLo | oral | 27mg/kg (27mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Pharmacotherapy Vol. 15, Pg. 528, 1995. |
| man | TDLo | oral | 70mg/kg/3W-I (70mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Journal of Clinical Psychiatry. Vol. 45, Pg. 358, 1984. |
| man | TDLo | unreported | 5714ug/kg/2D- (5.714mg/kg) | PERIPHERAL NERVE AND SENSATION: FASCICULATIONS BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Southern Medical Journal. Vol. 76, Pg. 1077, 1983. |
| monkey | LD | unreported | > 20mg/kg (20mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 1, 1979. | |
| mouse | LD50 | intraperitoneal | 112mg/kg (112mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: REGIDITY | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 233, Pg. 107, 1978. |
| mouse | LD50 | oral | 104mg/kg (104mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 1, 1979. |
| mouse | LD50 | subcutaneous | 385mg/kg (385mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 5, Pg. 1852, 1971. |
| rat | LD50 | intraperitoneal | 201mg/kg (201mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: REGIDITY BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 233, Pg. 107, 1978. |
| rat | LD50 | oral | 313mg/kg (313mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 5, Pg. 1852, 1971. |
| rat | LD50 | subcutaneous | > 4500mg/kg (4500mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 5, Pg. 1852, 1971. | |
| women | LDLo | oral | 40mg/kg (40mg/kg) | CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE CARDIAC: CHANGE IN RATE CARDIAC: OTHER CHANGES | Annals of Emergency Medicine. Vol. 17, Pg. 274, 1988. |
| women | LDLo | oral | 40mg/kg (40mg/kg) | BEHAVIORAL: COMA CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | JAMA, Journal of the American Medical Association. Vol. 250, Pg. 1069, 1983. |
| women | LDLo | oral | 75953ug/kg (75.953mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) CARDIAC: OTHER CHANGES CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | Forensic Science International. Vol. 26, Pg. 33, 1984. |
| women | TDLo | oral | 5mg/kg (5mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | JAMA, Journal of the American Medical Association. Vol. 250, Pg. 1069, 1983. |
| women | TDLo | oral | 15mg/kg/5D-I (15mg/kg) | ENDOCRINE: HYPERGLYCEMIA | Journal of Clinical Psychiatry. Vol. 44, Pg. 347, 1983. |
| women | TDLo | oral | 17mg/kg (17mg/kg) | BEHAVIORAL: COMA VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 101, 1983. |
| women | TDLo | oral | 30mg/kg (30mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE | JAMA, Journal of the American Medical Association. Vol. 248, Pg. 1092, 1982. |
| women | TDLo | oral | 50mg/kg (50mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA | Ugeskrift for Laeger. Doctor's Weekly. Vol. 146, Pg. 3285, 1984. |

